Learning outcomes
By the end of this lesson you should be able to: distinguish primary from secondary dysmenorrhoea and state the management of each; describe the pathophysiology and diagnosis of endometriosis and its treatment; state the diagnostic criteria, features and long-term consequences of polycystic ovary syndrome; describe the management of heavy menstrual bleeding and the place of a levonorgestrel intrauterine system; and distinguish the red-flag presentations that require gynaecological referral rather than symptomatic management.
Prerequisites
Lessons 1-5. Dysmenorrhoea, endometriosis and PCOS are all diseases of the menstrual cycle, and their management uses the mechanism of the cycle that you have learned.
The big idea
Three disorders account for most of what a gynaecologist sees in the reproductive years: dysmenorrhoea, endometriosis and polycystic ovary syndrome. Each is a different kind of problem: a painful period without pathology, ectopic endometrium that responds to the cycle, and a metabolic and ovulatory disorder that produces the cycle itself. What unifies them is that the treatment of each modifies the menstrual cycle, and the choice of modification is decided by the mechanism.
Worked example 1: dysmenorrhoea
| Type | Mechanism | Management |
|---|---|---|
| Primary dysmenorrhoea | Prostaglandins released by the shedding endometrium cause myometrial contraction and ischaemic pain; the uterus is normal and no pathology is present | A non-steroidal anti-inflammatory drug, which inhibits cyclo-oxygenase and therefore the prostaglandins; and a combined oral contraceptive, which reduces the endometrium |
| Secondary dysmenorrhoea | Pain caused by pathology — endometriosis, adenomyosis, fibroids or an intrauterine device | The treatment of the underlying cause, with an ultrasound to look for the pathology |
The distinction is made by history: primary dysmenorrhoea starts within a year or two of menarche, with the onset of ovulatory cycles, and the pain is in the lower abdomen and back and is worse with the flow. Secondary dysmenorrhoea that appears later, or that changes or worsens, means that something has grown, and the investigation must precede the analgesia.
Worked example 2: endometriosis
The classic features are dysmenorrhoea, dyspareunia and pain with defecation, together with infertility, and the pain is cyclical because the ectopic tissue responds to the hormones of the cycle. Deposits on the uterosacral ligaments and the pouch of Douglas are palpably tender on pelvic examination, and ovarian deposits form the endometriotic cyst (a chocolate cyst). Definitive diagnosis is by laparoscopy, but empirical treatment is started where the clinical suspicion is strong.
| Treatment | Mechanism | Use |
|---|---|---|
| Non-steroidal anti-inflammatory drugs and simple analgesia | Inhibit the prostaglandins of the implants | First-line symptom control |
| Combined hormonal methods or a progestogen | Suppress the cycle, so the ectopic tissue is not stimulated and not bleed | Suppression of the pain |
| Gonadotropin-releasing hormone analogues | Suppress the pituitary drive, producing a reversible hypo-oestrogenic state | For patients whose pain does not settle, with add-back hormone replacement to reduce the menopausal side effects |
| Laparoscopic excision or ablation | Removal of the deposits | Where the pain is refractory or fertility is the priority |
| In vitro fertilisation | Bypasses the adhesions | Where the tubal factor is primary |
Worked example 3: polycystic ovary syndrome
Polycystic ovary syndrome is a disorder of ovulatory function with a metabolic and endocrine background, and it is the commonest endocrine disorder of reproductive women. Its diagnosis needs two of the following three features: ovulatory dysfunction (irregular or absent cycles), clinical or biochemical evidence of androgen excess, and polycystic ovaries on ultrasound, with other causes excluded.
| Feature | Explanation |
|---|---|
| Irregular cycles or amenorrhoea | Anovulatory cycles with unopposed oestrogen |
| Hirsutism, acne and androgen-dependent hair loss | Androgen excess from the ovary and the adrenal gland |
| Infertility | The absence of ovulation |
| Obesity and insulin resistance | Insulin resistance raises insulin, which drives ovarian androgen production and the hyperinsulinaemia of the syndrome |
| Increased risk of endometrial hyperplasia | Unopposed oestrogen thickens the endometrium, and with the absence of progesterone the lining is not shed, which increases the long-term risk of endometrial cancer |
| Increased risk of type 2 diabetes and cardiovascular disease | The metabolic consequences of the insulin resistance |
The treatment is determined by the symptom that is most important to the patient. Weight loss and metformin restore ovulation and improve the metabolic profile, and letrozole (or clomifene) induces ovulation in a patient who wants a pregnancy. Combined hormonal contraception or a levonorgestrel intrauterine system produces regular withdrawal bleeds and protects the endometrium in a patient whose priority is the cycle, and the treatment of hirsutism is a combination of the mechanical and the pharmacological.
How does primary dysmenorrhoea differ from the dysmenorrhoea of endometriosis, and how does the difference change the management?
Common mistakes
Watch outSaying every woman with PCOS has polycystic ovaries on ultrasound. One of the three criteria is polycystic ovarian morphology, and the other two (ovulatory dysfunction and androgen excess) may be enough for the diagnosis in a woman whose follicles are not visibly polycystic.
Watch outSaying endometriosis can be diagnosed by ultrasound alone. Deposits and adhesions on the peritoneum are not seen by ultrasound; the definitive diagnosis is laparoscopy, though the endometrioma can be seen by ultrasound.
Watch outSaying a levonorgestrel intrauterine system treats all menorrhagia regardless of cause. It treats unexplained and dysfunctional menorrhagia and the bleeding of fibroids and endometriosis, but fibroids that are submucous and cavity-distorting require a surgical treatment.
Check your understanding
What are the diagnostic criteria for polycystic ovary syndrome?
Why does polycystic ovary syndrome increase the risk of endometrial cancer?
What is the mechanism of the treatment of primary dysmenorrhoea by a non-steroidal anti-inflammatory drug?
Multiple choice
What is the difference between primary and secondary dysmenorrhoea?
Which three features are the diagnostic criteria of polycystic ovary syndrome?
What is the mechanism by which polycystic ovary syndrome raises the risk of endometrial cancer?
Which is the first-line treatment of primary dysmenorrhoea?
Which is the most effective treatment for the pain of endometriosis?
Module summary and next
The commonest gynaecological disorders of the reproductive years all modify or disturb the menstrual cycle. Primary dysmenorrhoea is the pain of prostaglandins in a normal uterus and responds to an inhibitor of their synthesis; secondary dysmenorrhoea means pathology. Endometriosis is ectopic endometrium responding to the cycle, causing cyclical pain, dyspareunia and infertility, and treated by suppressing the cycle. Polycystic ovary syndrome is the commonest endocrine disorder of reproductive women, with ovulatory, androgenic and metabolic features, and the management restores a regular shedding of the endometrium and treats the symptom that matters most to the patient.
Next module: the physiology of pregnancy and antenatal care — where the anatomy and the cycles you have learned produce the clinical assessment of a pregnant woman.